Glenmark Life Sciences Ltd
NSE:GLS
Glenmark Life Sciences Ltd
Cash
Glenmark Life Sciences Ltd
Cash Peer Comparison
Competitive Cash Analysis
Latest Figures & CAGR of Competitors
Company | Cash | CAGR 3Y | CAGR 5Y | CAGR 10Y | |
---|---|---|---|---|---|
G
|
Glenmark Life Sciences Ltd
NSE:GLS
|
Cash
₹557.6m
|
CAGR 3-Years
697%
|
CAGR 5-Years
325%
|
CAGR 10-Years
N/A
|
Dr Reddy's Laboratories Ltd
NSE:DRREDDY
|
Cash
N/A
|
CAGR 3-Years
N/A
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
Cipla Ltd
NSE:CIPLA
|
Cash
N/A
|
CAGR 3-Years
N/A
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
Sun Pharmaceutical Industries Ltd
NSE:SUNPHARMA
|
Cash
N/A
|
CAGR 3-Years
N/A
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
Zydus Lifesciences Ltd
NSE:ZYDUSLIFE
|
Cash
₹4.1B
|
CAGR 3-Years
23%
|
CAGR 5-Years
13%
|
CAGR 10-Years
N/A
|
|
T
|
Torrent Pharmaceuticals Ltd
NSE:TORNTPHARM
|
Cash
N/A
|
CAGR 3-Years
N/A
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
See Also
What is Glenmark Life Sciences Ltd's Cash?
Cash
557.6m
INR
Based on the financial report for Mar 31, 2024, Glenmark Life Sciences Ltd's Cash amounts to 557.6m INR.
What is Glenmark Life Sciences Ltd's Cash growth rate?
Cash CAGR 5Y
325%
Over the last year, the Cash growth was 0%. The average annual Cash growth rates for Glenmark Life Sciences Ltd have been 697% over the past three years , 325% over the past five years .